Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-13

Clinical Trial Update: Vitamin D for Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluating vitamin D for schizophrenia, including clozapine-resistant cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Geha Mental Health Center | Conditions: Clozapine Resistant Schizophrenia | NA | Status: COMPLETED